202 related articles for article (PubMed ID: 17225279)
21. 144-week data released on Gilead's study 934.
AIDS Patient Care STDS; 2007 Aug; 21(8):603-4. PubMed ID: 17902243
[No Abstract] [Full Text] [Related]
22. High rate of virologic failure with once-daily ddI/3TC/TDF.
IAPAC Mon; 2003 Nov; 9(11):279. PubMed ID: 14989185
[No Abstract] [Full Text] [Related]
23. Emerging mutations at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine.
Maserati R; De Silvestri A; Uglietti A; Colao G; Di Biagio A; Bruzzone B; Di Pietro M; Re MC; Tinelli C; Zazzi M;
AIDS; 2010 Apr; 24(7):1013-8. PubMed ID: 20124969
[TBL] [Abstract][Full Text] [Related]
24. Effect of tenofovir subtraction on HIV plasma viraemia, CD4+ T-cell count and resistance in a patient with baseline K65R and M184V mutations.
Hsu R; Lanier ER; Rouse EG; Oie KL; Pappa KA; Ross LL
Antivir Ther; 2008; 13(5):735-7. PubMed ID: 18771059
[TBL] [Abstract][Full Text] [Related]
25. Tenofovir disoproxil fumarate-emtricitabine coformulation for once-daily dual NRTI backbone.
Muñoz de Benito RM; Arribas López JR
Expert Rev Anti Infect Ther; 2006 Aug; 4(4):523-35. PubMed ID: 17009933
[TBL] [Abstract][Full Text] [Related]
26. Anti-HIV agents. The puzzle of virologic failure with tenofovir.
TreatmentUpdate; 2004; 16(3):4. PubMed ID: 17216834
[No Abstract] [Full Text] [Related]
27. Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'.
Matthews GV; Dore GJ
AIDS; 2007 Mar; 21(6):777-8. PubMed ID: 17413705
[No Abstract] [Full Text] [Related]
28. FTC (emtricitabine, Emtriva).
Proj Inf Perspect; 2003 Oct; (36):6-7. PubMed ID: 14696567
[TBL] [Abstract][Full Text] [Related]
29. Editorial comment: tenofovir-related nephrotoxicity--who's at risk?
Gupta Samir K
AIDS Read; 2007 Feb; 17(2):102-3. PubMed ID: 17323509
[No Abstract] [Full Text] [Related]
30. Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.
Psevdos G; Gonzalez E; Sharp V
AIDS Read; 2009; 19(6):245-8. PubMed ID: 19642243
[TBL] [Abstract][Full Text] [Related]
31. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.
; Arrivé E; Chaix ML; Nerrienet E; Blanche S; Rouzioux C; Coffie PA; Kruy Leang S; McIntyre J; Avit D; Srey VH; Gray G; N'Dri-Yoman T; Diallo A; Ekouévi DK; Dabis F
AIDS; 2009 Apr; 23(7):825-33. PubMed ID: 19307941
[TBL] [Abstract][Full Text] [Related]
32. Editorial comment: mixing tenofovir with other nephrotoxins--how safe is this?
Gupta SK
AIDS Read; 2009; 19(6):246. PubMed ID: 19642244
[No Abstract] [Full Text] [Related]
33. Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study.
Stellbrink HJ; Orkin C; Arribas JR; Compston J; Gerstoft J; Van Wijngaerden E; Lazzarin A; Rizzardini G; Sprenger HG; Lambert J; Sture G; Leather D; Hughes S; Zucchi P; Pearce H;
Clin Infect Dis; 2010 Oct; 51(8):963-72. PubMed ID: 20828304
[TBL] [Abstract][Full Text] [Related]
34. New uses for tenofovir: more questions about d4T.
Proj Inf Perspect; 2003 Jan; (35):15-6. PubMed ID: 12647676
[TBL] [Abstract][Full Text] [Related]
35. [Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
Bayonne Kombo ES; Gathse A
Med Mal Infect; 2013 Mar; 43(3):134-5. PubMed ID: 23434355
[No Abstract] [Full Text] [Related]
36. Adipocyte differentiation, mitochondrial gene expression and fat distribution: differences between zidovudine and tenofovir after 6 months.
Boothby M; McGee KC; Tomlinson JW; Gathercole LL; McTernan PG; Shojaee-Moradie F; Umpleby AM; Nightingale P; Shahmanesh M
Antivir Ther; 2009; 14(8):1089-100. PubMed ID: 20032539
[TBL] [Abstract][Full Text] [Related]
37. Tenofovir--long term results from first-line therapy.
TreatmentUpdate; 2003; 15(2):4-6. PubMed ID: 12693361
[No Abstract] [Full Text] [Related]
38. French investigators warn of LPV/TDF/ddI interaction.
Carter M
IAPAC Mon; 2003 Dec; 9(12):315. PubMed ID: 15055164
[No Abstract] [Full Text] [Related]
39. Triple nuke therapy--results after one year.
TreatmentUpdate; 2001; 12(10):3-4. PubMed ID: 11570063
[No Abstract] [Full Text] [Related]
40. AACTG A5095, Trizivir, and the role of all-nucleoside regimens: an editorial.
Gallant JE
Hopkins HIV Rep; 2003 Jul; 15(4):1-2. PubMed ID: 14696559
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
